SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hypera Says Doctors Prescribe Semavy

Hypera sees an opportunity to expand Semavy prescriptions beyond endocrinologists and cardiologists, its president says.